semaglutide death A new study by EGDRC's Guillermo E Umpierrez found no difference in kidney outcomes among GLP-1 drugs dulaglutide, exenatide, liraglutide, but showed lower risk of and combined kidney/death outcomes in Semaglutide cuts risk for worsening

Tirzepatide is a synthetic peptide developed by Eli Lilly that activates the GLP-1 receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor

Psoriasis lesions tend to be thick and crusty and often form on the scalp, elbows, knees, and back

(1) Alternative Pathway Device Pass-Through Applications As discussed in the CY 2026 OPPS/ASC proposed rule, we received four device pass-through applications by the March 2025 quarterly application deadline for devices that have received Breakthrough Device designation from FDA and FDA marketing authorization for the indication for which they have a Breakthrough Device designation and, therefore were eligible to apply under the alternative pathway

Bellmann-Weiler, R